Codeine, ultrarapid-metabolism genotype, and postoperative death.
about
Codeine, alone and with paracetamol (acetaminophen), for cancer painCodeine, alone and with paracetamol (acetaminophen), for cancer painSystems pharmacology: network analysis to identify multiscale mechanisms of drug actionPharmacogenetics and anaesthesia: the value of genetic profilingPharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineOral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trialOxycodone overdose in the pediatric population: case files of the University of Massachusetts Medical Toxicology FellowshipRestricting cough and cold medicines in children.Clinical practice guideline: tonsillectomy in children.Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeClinical application of pharmacogenomics.Pharmacogenomic considerations in opioid analgesia.Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.Baby boy blue - why is this newborn lethargic?A review of perioperative anesthesia and analgesia for infants: updates and trends to watch.Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomyCopy number variants in pharmacogenetic genes.Parent satisfaction with acute pediatric pain treatment at home.Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.Pharmacogenetic testing: Current Evidence of Clinical Utility.Doing without codeine: why and what are the alternatives?Pharmacogenomics and adverse drug reactions in children.Personalized therapy in pain management: where do we stand?Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.Pharmacogenomics of opioids and perioperative pain management.The emerging era of pharmacogenomics: current successes, future potential, and challenges.Pharmacogenetic biomarkers for predicting drug response.To prescribe codeine or not to prescribe codeine?Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.Ethical perspectives on translational pharmacogenetic research involving children.Pediatric pain management in palliative care.Pharmacogenomics and Opioid Analgesics: Clinical Implications.Coblation versus other surgical techniques for tonsillectomy.Otolaryngology practice patterns in pediatric tonsillectomy: The impact of the codeine boxed warning.Post-tonsillectomy pain control: consensus or controversy?Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre.The Use of Ibuprofen in Posttonsillectomy Analgesia and Its Effect on Posttonsillectomy Hemorrhage Rate.The role of cytochrome P450 pharmacogenomics in chronic non-cancer pain patients.Lack of respiratory depression in paracetamol-codeine combination overdoses.
P2860
Q24193511-E616CF05-D918-455D-B904-5E23AE0B99D2Q24203016-A3CE73CB-0AA0-487B-B9F9-D83FDCF08098Q26824166-7C50625D-1547-4FEB-A058-F0C35A978308Q26859221-065FC583-11E3-4C9B-8708-44843EB1E383Q27692687-F3F68489-E4F3-43C4-9750-E005CC193302Q28650251-CC8BEC68-E62B-4BF6-931F-8D82715C1C4DQ34079053-0CE550CA-B43A-4416-ABAF-937A6E6B8004Q34123897-0B07755D-51F3-4452-AEA7-531706995D35Q34178385-15CA649F-0FB3-4DCB-9CB1-07C404A2138EQ34243414-3C4ED8B7-DAE0-47FA-99C9-633A7C043586Q34280685-1F542F1C-A482-4FD7-B6C8-506FC7707184Q34316700-BFACCCE3-779A-49B4-9B35-5BB3AF7771A2Q34399802-DA2F3088-666F-4116-AA81-FE2BFF9BD264Q34437058-37E1916E-37A7-40A0-A869-2E3BE8ED6D39Q34552020-B680B7F1-BBAC-4AAC-A26B-CDDF03A32FB0Q34872670-16205B24-89CB-47E0-B691-189C7FF70C6BQ34975631-E36CF33D-6AFE-489D-8652-38BB57737CCAQ35630908-7F4A8A87-34C3-4E1B-8A57-3B82A3DA81ACQ37047429-01085516-8F44-4F76-941A-1C712B820284Q37151528-C27AD925-7395-4488-AA46-85837278BDD1Q37717471-0BEB8124-4FC4-4C1F-8CE1-BF350A4575AAQ37719025-F5B9CE27-30DC-45AD-88DA-DEFAB762CA8AQ37760955-B2CF3530-0727-40C2-B8B2-DB06DEAA5316Q37872786-9B147886-1A3C-4C42-A5D7-73937AADB65FQ38061498-19E468E7-3ADA-40DD-835F-C1B0C6A83403Q38200683-7F9B6307-7E03-45C5-B88F-1C0F58BC12B0Q38214388-7295FA21-9BA9-4D3A-9779-8E3D0A453AC1Q38237742-995E3A59-8E27-42EA-8299-615D59ED0D10Q38260323-A9E632B9-90A5-4361-B034-F8C89FDD5148Q38287641-EF1C6A48-15A4-4DD4-A1DE-7443813C1868Q38299522-36488A31-AFE3-43A3-99AA-0C4412400B31Q38527869-A3807381-2E51-49FD-8E40-CFE22A55641AQ38614678-D1820C5D-B261-4B48-BEA6-8FAA2132AA8AQ38671618-F5207B95-1A36-4D25-97FF-87D9F8E73F3CQ38672184-D1947A16-A479-49EC-895C-2AD11119FF6AQ38731079-F8A5BB74-C4AC-410E-96FE-4FCE679086D6Q38833945-9A26485A-552E-4A49-8ACA-7F9CD0A1262EQ38836622-8DF79B1D-4F50-4516-99BE-20757B72CC01Q38844220-B908AD3F-174D-4AE4-B3F4-AA8B300C7D0DQ39051272-EAC1F1DF-528B-4978-94DF-A716E2FC6035
P2860
Codeine, ultrarapid-metabolism genotype, and postoperative death.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Codeine, ultrarapid-metabolism genotype, and postoperative death.
@en
Codeine, ultrarapid-metabolism genotype, and postoperative death.
@nl
type
label
Codeine, ultrarapid-metabolism genotype, and postoperative death.
@en
Codeine, ultrarapid-metabolism genotype, and postoperative death.
@nl
prefLabel
Codeine, ultrarapid-metabolism genotype, and postoperative death.
@en
Codeine, ultrarapid-metabolism genotype, and postoperative death.
@nl
P2093
P356
P1476
Codeine, ultrarapid-metabolism genotype, and postoperative death.
@en
P2093
Albert E Lauwers
Catherine Ciszkowski
Gideon Koren
Michael S Phillips
Parvaz Madadi
P304
P356
10.1056/NEJMC0904266
P407
P577
2009-08-01T00:00:00Z